These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30087144)

  • 1. Subjugation of TGFβ Signaling by Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma Shifts DNA Repair from Homologous Recombination to Alternative End Joining.
    Liu Q; Ma L; Jones T; Palomero L; Pujana MA; Martinez-Ruiz H; Ha PK; Murnane J; Cuartas I; Seoane J; Baumann M; Linge A; Barcellos-Hoff MH
    Clin Cancer Res; 2018 Dec; 24(23):6001-6014. PubMed ID: 30087144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
    Zuo N; Ma L; Liu T; Hu W; Luo Y; Meng H; Ren Q; Deng Y; Wei L; Liu Q
    Oral Oncol; 2023 May; 140():106367. PubMed ID: 36996606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misrepair in Context: TGFβ Regulation of DNA Repair.
    Liu Q; Lopez K; Murnane J; Humphrey T; Barcellos-Hoff MH
    Front Oncol; 2019; 9():799. PubMed ID: 31552165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas.
    Dok R; Bamps M; Glorieux M; Zhao P; Sablina A; Nuyts S
    Int J Cancer; 2020 Feb; 146(4):1075-1085. PubMed ID: 31283004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
    Tanaka N; Patel AA; Wang J; Frederick MJ; Kalu NN; Zhao M; Fitzgerald AL; Xie TX; Silver NL; Caulin C; Zhou G; Skinner HD; Johnson FM; Myers JN; Osman AA
    Clin Cancer Res; 2015 Nov; 21(21):4831-44. PubMed ID: 26124202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
    Liu C; Guo T; Xu G; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Khan Z; Fisch KM; Califano J
    Clin Cancer Res; 2018 Oct; 24(20):5123-5132. PubMed ID: 29945995
    [No Abstract]   [Full Text] [Related]  

  • 7. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
    Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
    Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATR inhibition sensitizes HPV
    Leonard BC; Lee ED; Bhola NE; Li H; Sogaard KK; Bakkenist CJ; Grandis JR; Johnson DE
    Oral Oncol; 2019 Aug; 95():35-42. PubMed ID: 31345392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Glial cell derived neurotrophic factor in head and neck cancer.
    Cao H; He Q; Eyben RV; Bloomstein J; Nambiar DK; Viswanathan V; Aggarwal S; Kwok S; Liang R; Koong AJ; Lewis JS; Kong C; Xiao N; Le QT
    PLoS One; 2020; 15(2):e0229311. PubMed ID: 32084217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma.
    An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y
    Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
    Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA double strand break repair defect and sensitivity to poly ADP-ribose polymerase (PARP) inhibition in human papillomavirus 16-positive head and neck squamous cell carcinoma.
    Weaver AN; Cooper TS; Rodriguez M; Trummell HQ; Bonner JA; Rosenthal EL; Yang ES
    Oncotarget; 2015 Sep; 6(29):26995-7007. PubMed ID: 26336991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.
    Berggren KL; Restrepo Cruz S; Hixon MD; Cowan AT; Keysar SB; Craig S; James J; Barry M; Ozbun MA; Jimeno A; McCance DJ; Beswick EJ; Gan GN
    Oncogene; 2019 Nov; 38(48):7329-7341. PubMed ID: 31417185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress.
    Lindemann A; Patel AA; Tang L; Tanaka N; Gleber-Netto FO; Bartels MD; Wang L; McGrail DJ; Lin SY; Frank SJ; Frederick MJ; Myers JN; Osman AA
    Mol Cancer Ther; 2021 Jul; 20(7):1257-1269. PubMed ID: 33947685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misregulation of DNA damage repair pathways in HPV-positive head and neck squamous cell carcinoma contributes to cellular radiosensitivity.
    Nickson CM; Moori P; Carter RJ; Rubbi CP; Parsons JL
    Oncotarget; 2017 May; 8(18):29963-29975. PubMed ID: 28415784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signature.
    Sailer V; Sailer U; Bawden EG; Zarbl R; Wiek C; Vogt TJ; Dietrich J; Loick S; Grünwald I; Toma M; Golletz C; Gerstner A; Kristiansen G; Bootz F; Scheckenbach K; Landsberg J; Dietrich D
    EBioMedicine; 2019 Oct; 48():341-352. PubMed ID: 31628024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy.
    Guix I; Liu Q; Pujana MA; Ha P; Piulats J; Linares I; Guedea F; Mao JH; Lazar A; Chapman J; Yom SS; Ashworth A; Barcellos-Hoff MH
    Clin Cancer Res; 2022 Apr; 28(7):1372-1382. PubMed ID: 35022323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types.
    Liu Q; Palomero L; Moore J; Guix I; Espín R; Aytés A; Mao JH; Paulovich AG; Whiteaker JR; Ivey RG; Iliakis G; Luo D; Chalmers AJ; Murnane J; Pujana MA; Barcellos-Hoff MH
    Sci Transl Med; 2021 Feb; 13(580):. PubMed ID: 33568520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
    Du S; Liu K; Gao P; Li Z; Zheng J
    Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer.
    Biktasova A; Hajek M; Sewell A; Gary C; Bellinger G; Deshpande HA; Bhatia A; Burtness B; Judson B; Mehra S; Yarbrough WG; Issaeva N
    Clin Cancer Res; 2017 Dec; 23(23):7276-7287. PubMed ID: 28916527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.